TY  - JOUR 
AU  - Leon Rapoport, B.
AU  - Garcia-Morillo, M.
AU  - Font, C.
AU  - Samoon, Z.
AU  - Jabbar, A.A.
AU  - Kourie, H.R.
AU  - Kayumba, A.
AU  - Esposito, F.
AU  - Popescu, R.A.
AU  - García. Gómez, Jesús
AU  - Heyman, L.
AU  - Smit, T.
AU  - Krendyukov, A.
AU  - Mathieson, N.
AU  - Cooksley, T.
AU  - Anderson, R.
AU  - Klastersky, J.
PY  - 2023
SN  - 1433-7339
UR  - http://hdl.handle.net/20.500.11940/20999
AB  - Purpose: Limited knowledge is available on the incidence of febrile neutropenia (FN) in intermediate-risk patients and the rationale for use of granulocyte colony-stimulating factor (G-CSF) in these patients. We aimed to estimate the rate at which...
LA  - eng
KW  - Humans
KW  - Middle Aged
KW  - Prospective Studies
KW  - Neoplasms
KW  - Granulocyte Colony-Stimulating Factor
KW  - Medical Oncology
KW  - Febrile Neutropenia
KW  - Antineoplastic Combined Chemotherapy Protocols
TI  - A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative
DO  - 10.1007/s00520-023-08071-0
T2  - Supportive Care in Cancer
KW  - AS Ourense
KW  - CHUO
VL  - 31
ER  -